Description

• The distinct modified dual release technique is the foundation of the pharmaceutical version of dexlansoprazole. The active component is released in two stages, each with a distinct pH and time interval. As a result, the medication reaches two blood peak concentrations, and the overall serum concentration of dexlansoprazole is three times greater.
• In order to match the dissolution characteristics of Dexlansoprazole Pellets with Innovator, MKPPL created Dexlansoprazole pellets using aqueous technology.
• The produced product is similar to the innovator in terms of the marketed product’s dissolving profile.
• If alternative formulations, doses, or strengths are needed, we provide development services. We also provide a full technical package for registrations in all regulated and semi-regulated markets.